These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 19317326

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Mortality in co-morbidity (II)--excess death rates derived from a follow-up study on 10,025 subjects divided into 4 groups with or without depression and diabetes mellitus.
    Milano AF, Singer RB.
    J Insur Med; 2007; 39(3):160-6. PubMed ID: 18251374
    [Abstract] [Full Text] [Related]

  • 3. Mortality in co-morbidity (I)--Analysis of the results in the Multiple Medical impairment Study for impairments with elevated blood pressure as the second or co-morbid impairment.
    Singer RB, Milano AF.
    J Insur Med; 2007; 39(2):78-88. PubMed ID: 17941332
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mortality in insureds with complete right or left bundle branch block.
    Singer RB.
    J Insur Med; 2007; 39(1):8-16. PubMed ID: 17500351
    [Abstract] [Full Text] [Related]

  • 7. Structured settlement annuities, part 2: mortality experience 1967--95 and the estimation of life expectancy in the presence of excess mortality.
    Singer RB, Schmidt CJ.
    J Insur Med; 2000; 32(3):137-54. PubMed ID: 15912914
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE).
    Okin PM, Oikarinen L, Viitasalo M, Toivonen L, Kjeldsen SE, Nieminen MS, Edelman JM, Dahlöf B, Devereux RB, LIFE Study Investigators.
    Circulation; 2009 Apr 14; 119(14):1883-91. PubMed ID: 19332468
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Treadmill value in apparently healthy life insurance applicants.
    Mihelic AH, Tak JA, Rullestad C.
    J Insur Med; 2002 Apr 14; 34(1):12-25. PubMed ID: 15303590
    [Abstract] [Full Text] [Related]

  • 15. Mortality in active adults age 70-79 years in relation to performance in a long-distance corridor walk.
    Singer RB.
    J Insur Med; 2009 Apr 14; 41(1):45-8. PubMed ID: 19518004
    [Abstract] [Full Text] [Related]

  • 16. Increased mortality associated with elevated carcinoembryonic antigen in insurance applicants.
    Stout RL, Fulks M, Dolan VF, Magee ME, Suarez L.
    J Insur Med; 2007 Apr 14; 39(4):251-8. PubMed ID: 18522142
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B, Beelen R, Hoek G, Schouten L, Bausch-Goldbohm S, Fischer P, Armstrong B, Hughes E, Jerrett M, van den Brandt P.
    Res Rep Health Eff Inst; 2009 Mar 14; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.